A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

This study is testing a device called the Eclipse XL1 System for people with short bowel syndrome (SBS) — a condition where much of the small intestine is missing or has been removed, making it very hard to absorb nutrients. The device works by gradually stretching the remaining intestine to help it grow longer and absorb more nutrients, reducing the need for IV nutrition. **You may be eligible if:** - You have short bowel syndrome, meaning you have 50% or less of the expected bowel length for your age or height - You have at least 3 cm of remaining bowel - You are between 3 months and 65 years old - You or your legal guardian can give informed consent and attend all study visits **You may NOT be eligible if:** - You have less than 3 cm of remaining bowel (ultra-short bowel syndrome) - You have Crohn's disease or another inflammatory bowel disease - You have active serious infections or other conditions that make surgery unsafe Talk to your doctor to see if this trial is right for you.